Jenburkt Pharmaceuticals share news, announcements and annual reports
NSE: JENBURPHBSE: 524731Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹853.60.
2 Nov: open ₹863.10, high ₹866.90, low ₹863.00
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹382 Cr1,871st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.64
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.39
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.39%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 53698.1% delivered
Jenburkt Pharmaceuticals share news and announcements
653 announcements, routine notices left out, newest first. Page 10 of 14.
Apr 2017
7 Apr · Statement Of Investors' Complaints Under Regulation 13(3) Of SEBI(Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Quarter Ended 31/03/2017
Mar 2017
Jan 2017
17 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
9 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Nov 2016
Oct 2016
13 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....8 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Jul 2016
12 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
7 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
May 2016
30 May · Meeting
Board of Directors of the Company at its meeting held on May 30, 2016, has transacted the following: 1. A Final Dividend of ....30 May · Authorised KMPs to determine materiality of events/information
19 May · Board meeting
Meeting of Board of Directors of the Company is scheduled to be held on May 30, 2016, inter alia, to consider: 1. To take on ....
Apr 2016
12 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....6 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Mar 2016
17 Mar · Shareholding for the Period Ended December 31, 2015
Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....10 Mar · Dividend
Board of Directors of the Company at its meeting held on March 10, 2016, have declared the Interim Dividend of Rs. 6.30 (i.e. 63%) ....8 Mar · Dividend
Company has fixed March 18, 2016 as the Record Date for the purpose of Payment of Interim Dividend, if declared.4 Mar · Board meeting
Meeting of the Board of Directors of the Company will be held on March 10, 2016, inter alia, to consider declaration of interim Dividend, if any. ....
Feb 2016
Jan 2016
13 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Oct 2015
9 Oct · Shareholding Pattern For September 30, 2015
Sep 2015
Jul 2015
27 Jul · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 02, 2015 to September 08, 2015 (both days ....24 Jul · Limited Review for June 30, 2015
24 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 24, 2015, inter alia, has transacted the following :- - The Board ....24 Jul · Results
24 Jul · Code of Conduct of Fair Disclosure
15 Jul · Shareholding Pattern For June 30, 2015
May 2015
12 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 21, 2015, inter alia to consider: 1. To take on record the ....8 May · Management
Mrs. Devangi Sanjeev Shah, a director on the Board of Directors of the Company have resigned from the directorship with effect from closing ....
Apr 2015